PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine IV, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.\', \'Department of General and Digestive Surgery, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.\', \'Department of Medicine II, Division of Infectious Diseases, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.\', \'Department of Medicine III (Interdisciplinary Medical Intensive Care), Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\', \'Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1371/journal.pone.0249760
?:doi
?:hasPublicationType
?:journal
  • PloS one
is ?:pmid of
?:pmid
?:pmid
  • 33974624
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.164
?:rankingScore_hIndex
  • 241
?:title
  • Therapy with lopinavir/ritonavir and hydroxychloroquine is associated with acute kidney injury in COVID-19 patients.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all